The efficacy of deep brain stimulation (DBS) for Parkinson disease (PD) is well established
for up to 1 or 2 years, but long-term outcome data are still limited. In this Review, we critically …

A robust body of evidence from randomized controlled trials has established the efficacy of
deep brain stimulation (DBS) in reducing off time and dyskinesias in levodopa‐treated …

Objective. Deep brain stimulation (DBS) is an established and valid therapy for a variety of
pathological conditions ranging from motor to cognitive disorders. Still, much of the DBS …

OBJECTIVE Deep brain stimulation (DBS) is an effective treatment for several movement
disorders, including Parkinson's disease (PD). While this treatment has been available for …

Objective To characterize how disease progression is associated with mortality in a large
cohort of patients with Parkinson disease (PD) with long-term follow-up after subthalamic …

Introduction: Although the benefit in motor symptoms for well-selected patients with deep
brain stimulation (DBS) has been established, cognitive declines associated with DBS can …

Introduction Parkinson's disease (PD) patients have a significantly higher risk of develo**
dementia in later disease stages, leading to severe impairments in quality of life and self …

Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or internal
globus pallidus (GPi) represents an effective and universally applied therapy for Parkinson's …

Multiple genes have been implicated in Parkinson disease pathogenesis, but the
relationship between regional expression of these genes and regional dysfunction across …

Worsening of verbal fluency after treatment with deep brain stimulation in Parkinson's
disease patients is one of the most often reported cognitive adverse effect. The underlying …